Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...

The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...

Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.

Milestone Pharmaceuticals (NASDAQ:MIST) shares jumped roughly 35% after the U.S. Food and Drug Administration approved ...

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given ...

The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...

PHILADELPHIA (WPVI) -- The human heart beats about a hundred thousand times a day. When the beat isn't regular, it's something called an arrhythmia. As we learn in today's Moves in Medicine, not all ...

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly ...

This page lists all known medications that could potentially lead to 'Supraventricular Arrhythmia' as a side effect. It's important to note that mild side effects are quite common with medications.

Milestone announced that the FDA approved Cardamyst, a novel nasal spray designed to rapidly resolve episodes of Paroxysmal ...

Ablation of supraventricular tachycardia in elderly persons presents a challenging problem to electrophysiologists. Friable cardiac structures, prone to catheter perforation, comorbid cardiovascular ...

Prog Cardiovasc Nurs. 2005;20(1):24-31. According to the site of origin of the impulse, the two classifications of SVT are atrial tachyarrhythmia and AV tachyarrhythmia. Atrial arrhythmias include ...